The Biotechnology for Europe Study

Consequences, opportunities and challenges

of modern biotechnology for Europe

Modern biotechnology is one of the key enabling technologies of the 21st century with a potentially wide range of applications in many sectors, including health, agriculture and industrial processes.

Considering the potential of modern biotechnology to contribute to the achievement of major European Union (EU) policy goals such as economic growth and job creation, public health, environmental protection and sustainable development, the European Parliament has requested the European Commission to carry out an assessment of modern biotechnology.

The European Commission welcomed the initiative and anounced to undertake a study "into and conduct a cost-benefit analysis of biotechnology and genetic engineering, including genetically modifed organisms, in the light of major European policy goals formulated in the Lisbon strategy, Agenda 21 and sustainable development".

For more information please click here.

Presentations made during the Concluding Symposium on the Bio4EU study and the revised EU Strategy on Life Sciences and Biotechnology on 20 April 2007, Brussels

For more information please click here.

Final Synthesis Report: Consequences, Opportunities and Challenges of Modern Biotechnology for Europe

To access the document please click here